Barr Laboratories, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for Pyridostigmine Bromide Tablets USP, 60 mg, the generic equivalent of ICN Pharmaceutical, Inc.'s Mestinon(R). The Company anticipates launching its product by the end of October ...